{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:21:03Z","timestamp":1759483263558},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Front. Med."],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11684-021-0850-9","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T07:03:31Z","timestamp":1625814211000},"page":"102-110","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with\/without hypertension"],"prefix":"10.1007","volume":"16","author":[{"given":"Huai-yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanghui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjun","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"issue":"18","key":"850_CR1","first-page":"1769","volume":"323","author":"AB Patel","year":"2020","unstructured":"Patel AB, Verma A. COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA 2020; 323(18): 1769\u20131770","journal-title":"JAMA"},{"issue":"18","key":"850_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18): 1708\u20131720","journal-title":"N Engl J Med"},{"issue":"4","key":"850_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020; 46(4): 586\u2013590","journal-title":"Intensive Care Med"},{"issue":"2","key":"850_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11684-020-0773-x","volume":"14","author":"G Zhou","year":"2020","unstructured":"Zhou G, Chen S, Chen Z. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies. Front Med 2020; 14(2): 117\u2013125","journal-title":"Front Med"},{"key":"850_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.phrs.2016.03.018","volume":"107","author":"E Sim\u00f6es","year":"2016","unstructured":"Sim\u00f6es E Silva AC, Teixeira MM. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis. Pharmacol Res 2016; 107: 154\u2013162","journal-title":"Pharmacol Res"},{"issue":"5","key":"850_CR6","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","volume":"318","author":"AM South","year":"2020","unstructured":"South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol 2020; 318(5): H1084\u2013H1090","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7047","key":"850_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005; 436(7047): 112\u2013116","journal-title":"Nature"},{"issue":"6","key":"850_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41581-020-0279-4","volume":"16","author":"AM South","year":"2020","unstructured":"South AM, Tomlinson L, Edmonston D, Hiremath S, Sparks MA. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol 2020; 16(6): 305\u2013307","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"850_CR9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","volume":"5","author":"J Li","year":"2020","unstructured":"Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol 2020; 5(7): 825\u2013830","journal-title":"JAMA Cardiol"},{"issue":"1","key":"850_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R, Di W, Wang Z, Li Z, Gao H, Liu L, Zhang G. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 2020; 9(1): 757\u2013760","journal-title":"Emerg Microbes Infect"},{"issue":"25","key":"850_CR11","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, Kunichoff D, Chen Y, Ogedegbe G, Hochman JS. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med 2020; 382(25): 2441\u20132448","journal-title":"N Engl J Med"},{"issue":"25","key":"850_CR12","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","volume":"382","author":"G Mancia","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med 2020; 382(25): 2431\u20132440","journal-title":"N Engl J Med"},{"issue":"9","key":"850_CR13","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","volume":"5","author":"N Mehta","year":"2020","unstructured":"Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, Milinovich A, Svensson LG, Jehi L, Young JB, Chung MK. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5(9): 1020\u20131026","journal-title":"JAMA Cardiol"},{"issue":"5","key":"850_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11684-020-0800-y","volume":"14","author":"J Xu","year":"2020","unstructured":"Xu J, Huang C, Fan G, Liu Z, Shang L, Zhou F, Wang Y, Yu J, Yang L, Xie K, Huang Z, Huang L, Gu X, Li H, Zhang Y, Wang Y, Hayden FG, Horby PW, Cao B, Wang C. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Front Med 2020; 14(5): 601\u2013612","journal-title":"Front Med"},{"key":"850_CR15","unstructured":"The National Health Commission of China. Diagnosis and Treatment Protocol for COVID-19 (Trial Version 7). 2020. http:\/\/en.nhc.gov.cn\/2020-03\/29\/c_78469.htm (accessed March 29, 2020)"},{"issue":"23","key":"850_CR16","first-page":"2526","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307(23): 2526\u20132533","journal-title":"JAMA"},{"issue":"8","key":"850_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors\/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 18(8): 891\u2013975","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"850_CR18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.amjmed.2012.07.015","volume":"125","author":"T Reichlin","year":"2012","unstructured":"Reichlin T, Twerenbold R, Reiter M, Steuer S, Bassetti S, Balmelli C, Winkler K, Kurz S, Stelzig C, Freese M, Drexler B, Haaf P, Zellweger C, Osswald S, Mueller C. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med 2012; 125(12): 1205\u20131213.e1","journal-title":"Am J Med"},{"key":"850_CR19","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Disease: Improving Global Outcomes\u2014CKD Evaluation and Management 2012. https:\/\/kdigo.org\/guidelines\/ckd-evaluation-and-management\/ (accessed March 29, 2020)"},{"issue":"6","key":"850_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/(SICI)1097-0258(19970330)16:6<611::AID-SIM437>3.0.CO;2-T","volume":"16","author":"NH Ng\u2019andu","year":"1997","unstructured":"Ng\u2019andu NH. An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox\u2019s model. Stat Med 1997; 16(6): 611\u2013626","journal-title":"Stat Med"},{"key":"850_CR21","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/dc20-0660","volume":"43","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yang D, Yang C, Zheng L, Huang K. Response to Comment on Chen et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care 2020; 43: 1399\u20131407. Diabetes Care 2020; 43(10): e165-e166","journal-title":"Diabetes Care"},{"issue":"12","key":"850_CR22","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, Liu YM, Zhao YC, Huang X, Lin L, Xia M, Chen MM, Cheng X, Zhang X, Guo D, Peng Y, Ji YX, Chen J, She ZG, Wang Y, Xu Q, Tan R, Wang H, Lin J, Luo P, Fu S, Cai H, Ye P, Xiao B, Mao W, Liu L, Yan Y, Liu M, Chen M, Zhang XJ, Wang X, Touyz RM, Xia J, Zhang BH, Huang X, Yuan Y, Loomba R, Liu PP, Li H. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 2020; 126(12): 1671\u20131681","journal-title":"Circ Res"},{"issue":"10","key":"850_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11906-017-0778-2","volume":"19","author":"S Culver","year":"2017","unstructured":"Culver S, Li C, Siragy HM. Intrarenal angiotensin-converting enzyme: the old and the new. Curr Hypertens Rep 2017; 19(10): 80","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"850_CR24","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/cvr\/cvaa097","volume":"116","author":"R Kreutz","year":"2020","unstructured":"Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res 2020; 116(10): 1688\u20131699","journal-title":"Cardiovasc Res"},{"issue":"30","key":"850_CR25","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.2174\/0929867324666170414162841","volume":"24","author":"L Anguiano","year":"2017","unstructured":"Anguiano L, Riera M, Pascual J, Soler MJ. Circulating ACE2 in cardiovascular and kidney diseases. Curr Med Chem 2017; 24(30): 3231\u20133241","journal-title":"Curr Med Chem"},{"issue":"11","key":"850_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/j.1552-4604.1993.tb01939.x","volume":"33","author":"RT Eberhardt","year":"1993","unstructured":"Eberhardt RT, Kevak RM, Kang PM, Frishman WH. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy. J Clin Pharmacol 1993; 33(11): 1023\u20131038","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"850_CR27","first-page":"482","volume":"14","author":"F Aghaaliakbari","year":"2020","unstructured":"Aghaaliakbari F, Abbasi MA, Ranjbar M, Jamshidi Makiani M, Farrokhpour M, Safarnezhad Tameshkel F, Karbalaie Niya MH, Doltkhah S, Yaghoobzadeh K, Savaj S. Angiotensin converting enzyme inhibitors, a risk factor of poor outcome in diabetic patients with COVID-19 infection. Iran J Kidney Dis 2020; 14(6): 482\u2013487","journal-title":"Iran J Kidney Dis"},{"issue":"3","key":"850_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jinf.2005.11.006","volume":"53","author":"F Guti\u00e9rrez","year":"2006","unstructured":"Guti\u00e9rrez F, Masi\u00e1 M, Mirete C, Sold\u00e1n B, Rodr\u00edguez JC, Padilla S, Hern\u00e1ndez I, Royo G, Martin-Hidalgo A. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 2006; 53(3): 166\u2013174","journal-title":"J Infect"},{"issue":"Suppl 6","key":"850_CR29","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","volume":"17","author":"M Woodhead","year":"2011","unstructured":"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections\u2014full version. Clin Microbiol Infect 2011; 17(Suppl 6): E1\u2013E59","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"850_CR30","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/cvr\/cvy013","volume":"114","author":"CH Chou","year":"2018","unstructured":"Chou CH, Hung CS, Liao CW, Wei LH, Chen CW, Shun CT, Wen WF, Wan CH, Wu XM, Chang YY, Wu VC, Wu KD, Lin YH; TAIPAI Study Group. IL-6 trans-signalling contributes to aldoster-one-induced cardiac fibrosis. Cardiovasc Res 2018; 114(5): 690\u2013702","journal-title":"Cardiovasc Res"},{"issue":"16","key":"850_CR31","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1161\/CIRCULATIONAHA.119.045102","volume":"141","author":"M Siedlinski","year":"2020","unstructured":"Siedlinski M, Jozefczuk E, Xu X, Teumer A, Evangelou E, Schnabel RB, Welsh P, Maffia P, Erdmann J, Tomaszewski M, Caulfield MJ, Sattar N, Holmes MV, Guzik TJ. White blood cells and blood pressure: a Mendelian randomization study. Circulation 2020; 141 (16): 1307\u20131317","journal-title":"Circulation"},{"issue":"5","key":"850_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1113\/expphysiol.2007.040048","volume":"93","author":"Y Imai","year":"2008","unstructured":"Imai Y, Kuba K, Penninger JM. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol 2008; 93(5): 543\u2013548","journal-title":"Exp Physiol"}],"container-title":["Frontiers of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-021-0850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11684-021-0850-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-021-0850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T18:52:15Z","timestamp":1648666335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11684-021-0850-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1007\/s11684-021-0850-9","relation":{},"ISSN":["2095-0217","2095-0225"],"issn-type":[{"value":"2095-0217","type":"print"},{"value":"2095-0225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"assertion":[{"value":"11 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}